|
|
The Swedish druguser union organised a policy dialogue meeting in Stockholm with support of the Correlation Network. See here their report  |
2nd International Forum of Social Street Workers
« Words from the street : street work, child rights, poverty and social exclusion »
Brussels, 26th to 30th October 2010
Information to download on forum2010 Website : www.street-work.net/en/
More information:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
Pilot online intervention tool.
Correlation - e-health is looking for Service Providers to participate in the development and testing of an online intervention tool.
Read more... |
|
New Harm Reduction Network established in Europe
On the recent harm reduction conference in Liverpool, a harm reduction network was launched within the European Union. Foundation Regenboog Groep (FRG) is one of the sub coordinators of the network, which is co-funded by the European Commission.
Please see more information about the network at: www.eurohrn.eu |
|
International conference in Münster, Germany, 6 - 7 October 2010:
Early Intervention in Europe - what can we learn from each other?
FreD goes net and other innovative projects of prevention.
Read more |
Resolution on viral hepatitis adopted by the 63rd World Health Assembly in
Geneva, read more >> |
|
The European project BORDERNETwork enters its second phase. The kick-off meeting will be held from june 30 until july 2 in Berlin.
Read more >> |
|
On the recent IHRA conference in Liverpool, Correlation took part in a major session on harm reduction in Europe.
'Harm Reduction from the grass root perspective: history, lessons learnt and what's next'
Read more
|
|
The Foundation Regenboog Groep (FRG), host of the Correlation project, is searching for a researcher / evaluator to take part in a European project on HIV/AIDS testing.
Please read here the terms of reference |
Correlation partner Svenska Brukarföringen
organises a seminar around peer support in Stockholm, Sweden. |
Correlation published its second newsletter,
addressing the topics of the upcoming seminars. |
Club Health 2010, 7 – 9 June 2010, X-TRA, Zurich, Switzerland
We are pleased to announce that the call for abstracts and registration for the leading international nightlife conference has been opened. Please visit our website at
www.clubhealthconference.com.
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
The conference is geared towards those working in: public health, substance use, sexual health, violence prevention, policing and criminal justice, tourism, nightlife industries, public transport, environmental health, general practice and therapy.
Registration Fee 350 Euros |
The European project H - Cube
published a report on HBV, HCV and HIV/AIDS among young people in the EU, including definition of the 3 diseases, an epidemiological overview, best practices in prevention and information activities and currently legislation.
You can download the complete report at the following link:
http://share.associazioneises.org/HCUBE/D3_analysis_local_contexts.pdf |
Gay Health Network Newsletter issue 6
Download here |
|
The Second General Meeting of the Correlation Network took place in Porto, Portugal, from 4 - 6 March 2010.
More than 110 experts from all over Europe continued to work on issues in the field of outreach, peer support, eHealth, hepatitis c and HIV/AIDS policy.
For more information plaese contact:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
|
The International Harm Reduction Association' s (IHRA) 21st International Conference takes place in Liverpool from 24 - 28 May 2010
CORRELATION is contributing to several sessions: On Harm reduction in Europe, on drug consumption rooms and on peer support. Please visit www.ihraconferences.net for further information |
|
The Institute of Medicine (IOM)/CDC US has released a report,
"Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C," (at www.cdc.gov/hepatitis/PDFs/IOM-HepatitisAndLiverCancerReport.pdf ) raises the visibility of the burden of viral hepatitis and identifies priorities for research, policy, and action. The IOM report confirms the vision long shared by CDC and public health partners—that it is possible to stem the tide of viral hepatitis by scaling up efforts and expanding on proven strategies, and that both prevention and early intervention for chronic viral hepatitis can help save lives.
The key recommendation provided here is the need to acknowledge hepatitis as a threat for public health, screening and care for all people in need.
At the same time also IOM announce a new website that is being launched from a CDC-funded training center at the University of Alabama at Birmingham. This web site, www.KnowHepatitis.org, features a discussion by Dr. John Ward, director of CDC’s Division of Viral Hepatitis, on the IOM report recommendations. |
|
Correlation partner HCLU presents the results of its video advocacy work in 2009, in a new report published recently:
http://tasz..hu/en/hclu-film/hclu-films-portfolio-2009
HCLU produced 70 films in 2009, 26 in Hungarian and 44 in English.
|
|
International AIDS Conference Vienna 2010
Message from the Network of Sex Worker Projects.
Less than one month until the deadline for submissions (and scholarship
applications!) for the International AIDS Conference!
Did you put in a submission? An abstract for a presentation or a Global
Village activity? Applied for a scholarship? Please let us know! We are
keeping track of sex work related sessions and activities and will have
this information ready for you at the conference.
Need support with sorting through the possibilities of participating or
with transforming your work/project/study into the "conference abstract
form"? Get in touch with us! There are regional abstract support persons
who kindly volunteered to help out. Let us know in time! Send your drafts
by 20th January 2010.
IMPORTANT NEWS: The NSWP will have a small fund to support sex worker
participation at the AIDS conference. This will be used to support those
who submitted an abstract/presentation/activity which was accepted and who
(within the deadline) requested a scholarship from the official
scholarship programme but have been refused. Let us know when you receive
an official notification about your submissions and applications from the
conference organisers.
Also, check out the NSWP-website for regular updates on the conference
preparations: www.nswp.org
|
|
The European Project Connections announces it's second conference on Drugs, Alcohol and Criminal Justice, 23 - 25 June in London.
Read more
|
|
TAMPEP's pan-European network
recently launched new products as a result of a two year project period.
Please check www.tampep.eu for the manual 'work safe in sex work ' and other materials.
|
|
The European Commission has published a strategy for combating HIV/AIDS in the EU and neighbouring countries 2009-2013
Today, the Commission has renewed its efforts to fight HIV/AIDS in the EU and neighbouring countries by adopting a strategy for the period 2009-2013. Effective HIV treatment exists but there is still no cure or vaccine against AIDS. The number of people living with HIV/AIDS in the EU and neighbouring countries has increased from 1.5 million in 2001 to 2.2 million in 2007. Approximately 730,000 of these people live in the EU. With 50 000 newly diagnosed HIV cases in the EU and the neighbouring countries alone in 2007, there is no time for complacency. Disparities exist between the numbers of HIV cases and the different modes of transmission across Europe. The strategy tackles these differences by concentrating on 3 key areas: HIV prevention and HIV testing, priority groups most at risk of HIV and priority regions. The strategy is accompanied by an action plan which illustrates concrete steps, target groups and evaluation tools that can be used to measure progress.
The overall objectives of this Strategy are: (i) to reduce new HIV infections across all European countries by 2013, (ii) to improve access to prevention, treatment, care and support and (iii) to improve the quality of life of people living with, affected by or most vulnerable to HIV/AIDS in the European Union and neighbouring countries.
The strategy calls on all key actors including national authorities and NGOs to work on:
- improving information for all, especially targeting young people who have missed the successful HIV communication campaigns in the past
- addressing migrants from countries with a high prevalence of HIV to make them knowledgeable on preventing transmission, HIV testing and treatment options
- improving policies targeting, in particular, the populations most at risk, emphasising human rights, and addressing discrimination and stigma associated to HIV/AIDS
Please find here the entire file
|
|
Correlation published it's first newsletter with reports from the first General Meeting and project activities.
Please download the newsletter here as pdf or contact the administration for a print version.
read more >>
|
|
HIV-Positive Injecting Drug Users Respond as Well as Non-Drug Injectors to First-Line Therapy
HIV-positive injecting drug users (IDUs) can be treated as successfully as HIV-positive non-IDUs, researchers stated here at the 5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Cape Town, South Africa.
HIV-Positive Injecting Drug Users Respond as Well as Non-Drug Injectors to First-Line Therapy [Presentation title: Response to First Line Antiretroviral Therapy Among HIV-Infected Patients With and Without a History of Injecting Drug Use in Indonesia. Abstract MOPEB060]
CAPE TOWN, South Africa -- July 27, 2009 -- HIV-positive injecting drug users (IDUs) can be treated as successfully as HIV-positive non-IDUs, researchers stated here at the 5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention.
"There is a common belief that injecting drug use is associated with lower uptake, retention, and success of antiretroviral treatment in HIV-infected patients, although studies in western countries have shown this is not always the case," said Rudi Wisaksana, MD, Department of Internal Medicine, Hasan Sadikin Hospital of Padjadjaram University, Bandung, Indonesia.
In an examination of response to first-line treatment for HIV infection, Dr. Wisaksana said that 53% of 530 HIV-positive IDUs were alive on their original treatment regimen after 6 months of treatment compared with 55.2% of 96 HIV-positive non-IDUs.
Another 14% of the IDUs were alive on an alternate regimen as were 7.3% of the non-IDUs, Dr. Wisaksana said at a poster presentation on July 20.
Of the IDUs, 15.7% had died compared with 18.8% of the non-IDUs (P = .46), a nonsignificant difference. About 13% of patients in each group were lost to follow-up.
"HIV-patients with a history of injecting drug use in this setting were mostly young males, presenting with hepatitis C virus coinfection, and more severe immunosuppression than HIV-patients without a history of injecting drug use," said Dr. Wisaksana.
About 91% of the IDUs were men compared with only 27.1% of the non-IDUs. The mean age for the patients in the study was 28 years. About half the IDUs were single while 55.8% of the non-IDUs were married.
About 87.7% of the IDUs were positive for hepatitis C virus compared with none of the non-IDUs, and about 8% of IDUs showed exposure to hepatitis B virus compared with 3.3% of non-IDUs.
"We found that injecting drug use did not have a negative effect on mortality, retention in treatment, and virological or immunological response to antiretroviral therapy," Dr. Wisaksana said.
|
|
5 Reports by Professor Jane Fountain
The National Treatment Agency for Substance Misuse (NTA) in England has just published 5 reports by Professor Jane Fountain on issues surrounding drug use and drug services among different ethnic populations in England (South Asian; Black African; Black Caribbean; Kurdish, Turkish Cypriot and Turkish; and Chinese and Vietnamese).
These are the results of the Department of Health’s Black and minority ethnic drug misuse needs assessment project that was conducted three phases during 2000-2001, 2004-2005, and 2006. In this project, 179 Black and minority ethnic community organisations were trained and supported by UCLan to conduct needs assessments among their own communities, using the Community Engagement Model.
The total sample size across the 5 reports is 18,715.
The NTA has published these reports alongside its own report of good practice in diversity and says 'This is the first detailed investigation into knowledge of drugs and drug services among a range of black and minority ethnic groups in England...The NTA endorses these reports and is grateful to UCLAN for its insights, which have been incorporated into the annual needs assessment and treatment planning process'.
The reports are available at http://www.nta.nhs.uk/publications/publications.aspx?CategoryID=0
For further details, contact:Jane FountainProfessor of Substance Use ResearchInternational School for Communities, Rights and Inclusion (ISCRI)University of Central LancashirePreston, UK
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
|
First Correlation II General Meeting18th - 20th of June in Amsterdam, the Netherlandsto which more than 90 experts from all over Europe attended.
Please see here the program >>
Please see here the report >> |
|
Report Symposium
See here the report of the symposium 'drug policy between law enforcement and health policy''( in Dutch) organised by the Correlation Network in December 2008 in Amsterdam. |
|
|
|
|
